4,532 results match your criteria: "Hospital Universitari Germans[Affiliation]"
Arch Bronconeumol
October 2024
Sleep Medicine Unit, Respiratory Medicine Department, Direcció Clínica de l'Àrea del Tòrax, Hospital Universitari Germans Trias i Pujol, Badalona, Spain; Fundació Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, Department of Respiratory Medicine, Badalona, Spain.
J Affect Disord
September 2024
Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, Québec, Canada; Department of Medicine, McGill University, Montréal, Québec, Canada; Department of Psychiatry, McGill University, Montréal, Québec, Canada; Department of Psychology, McGill University, Montréal, Québec, Canada; Biomedical Ethics Unit, McGill University, Montréal, Québec, Canada.
Span J Psychiatry Ment Health
June 2024
Institut de Neuropsiquiatria i Adiccions (INAD), Parc de Salut Mar, Barcelona, Spain; Centro de Investigación Biomédica en Red en Salud Mental (CIBERSAM), Barcelona, Spain; Fundació Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain.
Background: Approximately 20-30% of patients with schizophrenia fail to respond to antipsychotic treatment and are considered treatment resistant (TR). Although clozapine is the treatment of choice in these patients, in real-world clinical settings, clinicians often delay clozapine initiation, especially in first-episode psychosis (FEP).
Aim: The main aim of this study was to describe prescription patterns for clozapine in a sample of patients diagnosed with FEP and receiving specialized treatment at a university hospital.
Res Sq
June 2024
Institute for Genomic Statistics and Bioinformatics, University of Bonn, Bonn, NRW, Germany.
Surg Endosc
August 2024
Gastroenterology Department, Hospital Universitari Germans Trias i Pujol, Carretera del Canyet s/n, 08916, Badalona, Catalonia, Spain.
Background: The growing incidence of lower gastrointestinal bleeding (LGIB) is leading to a rise in-hospital admissions even though most LGIB episodes are self-limiting. The Oakland and SHAPE scores were designed to identify patients best suited to outpatient care. Our aim is explore the validity of the SHAPE score and compare both of these scores in terms of predictiveness of safe discharge.
View Article and Find Full Text PDFPLoS Negl Trop Dis
June 2024
Clinical Research Department, London School of Hygiene & Tropical Medicine, London, United Kingdom.
Breast Cancer Res Treat
November 2024
Gynaecology Department, Miguel Servet University Hospital, Saragossa, Spain.
Purpose: To assess the reliability of excising residual breast cancer lesions after neoadjuvant systemic therapy (NAST) using a previously localized paramagnetic seed (Magseed®) and the subsequent use of contrast-enhanced spectral mammography (CESM) to evaluate response.
Methods: Observational, prospective, multicenter study including adult women (> 18 years) with invasive breast carcinoma undergoing NAST between January 2022 and February 2023 with non-palpable tumor lesions at surgery. Radiologists marked tumors with Magseed® during biopsy before NAST, and surgeons excised tumors guided by the Sentimag® magnetometer.
ESC Heart Fail
October 2024
Heart Institute, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
Aims: In low-risk patients with severe aortic stenosis (AS), sutureless surgical aortic valve replacement (SU-SAVR) may be an alternative to transcatheter aortic valve implantation (TAVI). The risk of heart failure hospitalization (HFH) after aortic valve replacement (AVR) in this population is incompletely characterized. This study aims to investigate the incidence, predictors, and outcomes of HFH in patients undergoing SU-SAVR versus TAVI.
View Article and Find Full Text PDFDiagnostics (Basel)
May 2024
Department of Ophthalmology, Hospital Clínic de Barcelona, 08036 Barcelona, Spain.
In the original publication [...
View Article and Find Full Text PDFNutrients
May 2024
Gastroenterology Department, Hospital Universitari Germans Trias i Pujol, 08029 Badalona, Spain.
Background: The diagnosis of coeliac disease (CD) in adults is based on clinical, serological and histological criteria. The inappropriate performance of intestinal biopsies, non-specificity of mild histological lesions and initiation of a gluten-free diet (GFD) before biopsy may hamper the diagnosis. In these situations, determining the intraepithelial lymphogram of the duodenum by flow cytometry (IEL-FC) can be helpful.
View Article and Find Full Text PDFPatients hospitalized with COVID-19 have low levels of vitamins and trace elements. This could lead to a post-acute COVID-19 condition (PCC) that can worsen a patient's quality of life. We aimed to study the baseline micronutrient status of patients and assess whether a multiple micronutrient supplement (MMS) taken for 2 weeks at the first sign of COVID-19 symptoms would be able to reduce the incidence of PCC.
View Article and Find Full Text PDFHeart Rhythm
December 2024
Arrhythmia Unit, Cardiology Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain; Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain; CIBER de Enfermedades Cardiovasculares (CIBER-CV), Instituto de Salud Carlos III, Madrid, Spain.
Arch Bronconeumol
October 2024
Respiratory Medicine Department, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain; Germans Trias i Pujol Research Institute (IGTP), Badalona, Barcelona, Spain; Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain.
Introduction: Early diagnosis of lung cancer (LC) is crucial to improve survival rates. Radiomics models hold promise for enhancing LC diagnosis. This study assesses the impact of integrating a clinical and a radiomic model based on deep learning to predict the malignancy of pulmonary nodules (PN).
View Article and Find Full Text PDFDig Liver Dis
December 2024
Gastroenterology Department, Hospital Universitario Miguel Servet, Zaragoza, Spain.
Background: some patients with inflammatory bowel disease (IBD) treated with antiTNF develop drug-induced psoriasis (antiTNF-IP). Several therapeutic strategies are possible.
Aims: to assess the management of antiTNF-IP in IBD, and its impact in both diseases.
Neurology
July 2024
From the Department of Neurology (J.M.-F., A.R.-P., L.P.-S., M.G.-J., A.M.-D., R.M., Á.L.-G., G.E.D., P.C.-R.), Hospital de la Santa Creu i Sant Pau, Barcelona; Department of Neurology (A.N.-G., B.L.R., A.P.-M., H.Q.), Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat; Department of Neurology (D.R.-L.), Hospital Vall d'Hebron, Barcelona; Department of Neurology (S. Amaro, L.L.), Hospital Clínic Barcelona; Department of Neurology (Y.S., M.P.C.), Hospital Universitari Dr Josep Trueta, Girona; Department of Neurology (A.R.-C., E.G.S.), Hospital del Mar, Barcelona; Department of Neurology (I.P., D.W., N.P.D.L.O., O.F.), Hospital Universitari Germans Trias i Pujol, Badalona; Department of Neurology (M.G.-C.), Complex Hospitalari Universitari Moisès Broggi, Sant Joan Despí; Department of Neurology (D.V.-J.), Hospital Universitari Arnau de Vilanova, Lleida; Department of Neurology (N.G.), Consorci Sanitari del Maresme, Mataró; Department of Neurology (D. Cocho), Hospital General de Granollers, Granollers; Department of Neurology (D. Cánovas), Hospital Universitari Parc Taulí, Sabadell; Department of Neurology (O.P., N.R.-V.), Hospital Universitari Vall d'Hebron; Department of Neurology (L.S.), Hospital Universitari Joan XXIII, Tarragona; Hospital Universitari d'Igualada, Igualada (J.P.); Hospital de Figueres (X.C.), Figueres; Department of Neurology (J.Z.), Hospital Verge de la Cinta, Tortosa; Consorci Sanitari Alt Penedès-Garraf (E.C.), Vilafranca del Penedés; Xarxa Assistencial Universitària Manresa (N.M.C.), Manresa; Department of Neurology (J.K.), Hospital Universitari Mútua de Terrassa, Terrassa; Stroke Programme (S. Abilleira), Health Department of Catalonia, Barcelona; and Catalan Health Department (M.S.-P., O.F.), Agency for Health Quality and Assessment of Catalonia, Barcelona, Spain.
Background And Objectives: Whether the outcome of patients with spontaneous intracerebral hemorrhage (ICH) differs depending on the type of hospital where they are admitted is uncertain. The objective of this study was to determine influence of hospital type at admission (telestroke center [TSC], primary stroke center [PSC], or comprehensive stroke center [CSC]) on outcome for patients with ICH. We hypothesized that outcomes may be better for patients admitted to a CSC.
View Article and Find Full Text PDFEur J Heart Fail
July 2024
Duke Clinical Research Institute, Durham, NC, USA.
Obes Res Clin Pract
July 2024
Cardiology Department, Hospital Clínico Universitario, INCLIVA, Universitat de València, Valencia, Spain; CIBER Cardiovascular, Spain. Electronic address:
This study investigates the association between maximal functional capacity (peakVO) and N-terminal pro-brain natriuretic peptide (NT-proBNP) in 133 ambulatory patients with heart failure with preserved ejection fraction (HFpEF), focusing on patients with obesity. Across all participants, NT-proBNP inversely correlated with peakVO. However, this association varied based on obesity status.
View Article and Find Full Text PDFFront Immunol
June 2024
GSK, Brentford, United Kingdom.
Introduction: Fostemsavir is a gp120-directed attachment inhibitor approved for heavily treatment-experienced (HTE) adults with multidrug-resistant HIV-1. We provide detailed week 240 safety results from the BRIGHTE study and evaluate the impact of immune recovery on safety outcomes.
Methods: The phase 3 BRIGHTE trial is ongoing; data for this analysis were collected from the first participant's first visit (February 23, 2015) through the last participant's last visit for week 240 (March 22, 2021).
Int J Gynecol Cancer
August 2024
Dana Farber Cancer Institute, Boston, Massachusetts, USA.
Cir Esp (Engl Ed)
August 2024
Unidad de Cirugía Hepatobiliopancreática, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain.
BMC Microbiol
June 2024
IrsiCaixa, Ctra de Canyet S/N, 08916, Badalona, Spain.
Background: People living with HIV (PLWH) are at increased risk of acquisition of multidrug resistant organisms due to higher rates of predisposing factors. The gut microbiome is the main reservoir of the collection of antimicrobial resistance determinants known as the gut resistome. In PLWH, changes in gut microbiome have been linked to immune activation and HIV-1 associated complications.
View Article and Find Full Text PDFTransplant Cell Ther
September 2024
Department of Hematology, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Department of Hematology, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain. Electronic address:
Sinusoidal obstruction syndrome/veno-occlusive disease (SOS/VOD) is a life-threatening complication after both autologous and allogeneic hematopoietic stem cell transplantation (HSCT). However, its characterization after haploidentical HSCT (haplo-HSCT) with post-transplantation cyclophosphamide (PT-Cy) is scarce. This study aimed to describe characteristics and outcomes of patients with SOS/VOD after haplo-HSCT with PT-Cy.
View Article and Find Full Text PDFEur J Heart Fail
July 2024
Centro Academico de Medicina de Lisboa, CCUL@RISE, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal.
Aim: The RESHAPE-HF2 trial is designed to assess the efficacy and safety of the MitraClip device system for the treatment of clinically important functional mitral regurgitation (FMR) in patients with heart failure (HF). This report describes the baseline characteristics of patients enrolled in the RESHAPE-HF2 trial compared to those enrolled in the COAPT and MITRA-FR trials.
Methods And Results: The RESHAPE-HF2 study is an investigator-initiated, prospective, randomized, multicentre trial including patients with symptomatic HF, a left ventricular ejection fraction (LVEF) between 20% and 50% with moderate-to-severe or severe FMR, for whom isolated mitral valve surgery was not recommended.
Farm Hosp
June 2024
Servicio de Farmacia, Hospital de Sagunto, Valencia, España.
Objective: To determine the degree of knowledge about biological therapy and biosimilars in patients with immune-mediated inflammatory diseases treated in Outpatient Pharmaceutical Care Units.
Methods: Observational, prospective and multicenter study during the period May 2020-March 2021. A survey (9 questions) was conducted before starting treatment in which the patients' level of knowledge about biological therapy and biosimilars was assessed.
Pharmacol Res
August 2024
Hospital Universitari Germans Trias I Pujol and Fundació Germans Trias I Pujol (HUGTiP-IGTP), Carretera de Canyet, s/n, Badalona 08916, Spain; Universitat Autònoma de Barcelona (UAB), Cerdanyola del Vallès 08193, Spain. Electronic address:
Substance use disorders (SUD), also named addiction when it is severe, is a chronic brain disorder with serious impact on individual who suffer, the public health and with high burden of disease. They are multitude of mechanisms/factors involved in addiction: from individual characteristics of the person (from genetic to impacts of stress, sex, and age) to social and environmental situation (availability and accessibility of substances, cultural and legal aspects, socio-economical situation) and type of substance of use (pharmacological characteristics) Then, research on Addiction must include different, complementary, and translational perspectives. In this review, we explore the neurobiological, psychosocial, and epidemiological knowledge of substance addiction, and the main role played by pharmacology in the research in this field.
View Article and Find Full Text PDF